Advertisement

Aging Clinical and Experimental Research

, Volume 21, Issue 3, pp 258–263 | Cite as

Life course vaccination and healthy aging

  • Michael K. Gusmano
  • Jean-Pierre Michel
Review Article

Abstract

The authors notice the low vaccine coverage rate among European citizens and inventory the multiple reasons leading to the non-use of preventable infectious diseases vaccines in adults whose mortality consequences represent an important and unexpected burden of diseases. These facts are in close relation with the disruption of vaccine recommendations after the childhood vaccine program, the poor literacy knowledge concerning vaccines among the general population, but also unfortunately among physicians and other health care workers. Popular beliefs, fear of side-effects, fear of needles facilitated the constitution of active non-vaccine groups which conduct to the reappearance in non-vaccinated adults and with dramatic consequences of preventable childhood infectious diseases. This careful analysis of the current preventable infectious disease vaccine coverage in old adults leads to propose a life course vaccine programme including adult vaccinations as part of healthy aging as well as old adults’ vaccine guidelines integrated in health prevention programs.

Keywords

Adults barriers to vaccinate life course vaccines vaccine incentives 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Madelin R. Future challenges for EU health and customer policy. In SANCO D-GfHCD, ed. Brussels: European commission, 2008.Google Scholar
  2. 2.
    Fingar AR, Francis BJ. American College of Preventive Medicine Practice Policy Statement: adult immunizations. Am J Prev Med 1998; 14: 156–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Szucs TD, Muller D. Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 2005; 23: 5055–63.PubMedCrossRefGoogle Scholar
  4. 4.
    Christenson B, Pauksen K, Sylvan SP. Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity. Virol J 2008; 5: 52.PubMedCrossRefGoogle Scholar
  5. 5.
    Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998; 158: 1769–76.PubMedCrossRefGoogle Scholar
  6. 6.
    Vitek CR, Wharton M. Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis 1998; 4: 539–50.PubMedCrossRefGoogle Scholar
  7. 7.
    Richard J, Masserey-Spicher V, Santibanez S, Mankertz A. Measles outbreak in Switzerland—an update relevant for the European football championship (EURO 2008). Euro Surveill 2008; 13.Google Scholar
  8. 8.
    de Greeff SC, Mooi FR, Schellekens JF, de Melker HE. Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands. Pediatr Infect Dis J 2008; 27: 218–23.PubMedCrossRefGoogle Scholar
  9. 9.
    Centers for Disease Control and Prevention (CDC). Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998–2003. MMWR Morb Mortal Wkly Rep 2005; 54: 893–7.Google Scholar
  10. 10.
    Patel MS, Davis MM. Could a federal program to promote influenza vaccination among elders be cost-effective? Prev Med 2006; 42: 240–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357: 1373–81.PubMedCrossRefGoogle Scholar
  13. 13.
    Prosser LA, Bridges CB, Uyeki TM et al. Health benefits, risks, and cost-effectiveness of influenza vaccination of children. Emerg Infect Dis 2006; 12: 1548–58.PubMedCrossRefGoogle Scholar
  14. 14.
    Evers SM, Ament AJ, Colombo GL et al. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. Eur J Clin Microbiol Infect Dis 2007; 26: 531–40.PubMedCrossRefGoogle Scholar
  15. 15.
    Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003; 52: 1–34; quiz CE1-4.Google Scholar
  16. 16.
    Grubeck-Loebenstein B, Della Bella S, Iorio AM, Michel J-P, Pawelec G, Solana R. Immunosenescence and vaccine failure in the elderly. Aging Clin Exp Res 2009; 21: 201–9.PubMedGoogle Scholar
  17. 17.
    Nowalk MP, Zimmerman RK, Shen S, Jewell IK, Raymund M. Barriers to pneumococcal and influenza vaccination in older community-dwelling adults (2000–2001). J Am Geriatr Soc 2004; 52: 25–30.PubMedCrossRefGoogle Scholar
  18. 18.
    Salmasco S, Appelgren E, Bacci S et al. The Vaccine European New Integrated Collaboration Effort (VENICE). In: European Health Forum. Gastein: http://venice.cineca.org; 2008.
  19. 19.
    Waters HR, Hobart J, Forrest CB et al. Health insurance coverage in Central and Eastern Europe: trends and challenges. Health Aff (Millwood) 2008; 27: 478–86.CrossRefGoogle Scholar
  20. 20.
    Zatonski W. The East-West Health Gap in Europe—what are the causes? Eur J Public Health 2007; 17: 121.PubMedCrossRefGoogle Scholar
  21. 21.
    Cruz-Jentoft AJ, Franco A, Sommer P et al. European Silver Paper on the Future of Health Promotion and Preventive Actions, Basic Research and Clinical Aspects of Age-Related Disease. A consensus report of the outcome of the European Summit on Age Related Disease In: Wroclaw Summit in Ageing; 2008; Wroclaw: Gerontechjournal; 2008.Google Scholar
  22. 22.
    CDC. Most adults aren’t immunized against serious infectious diseases. Medical News Today 2008.Google Scholar
  23. 23.
    Freed GL, Freeman VA, Clark SJ, Konrad TR, Pathman DE. Pediatrician and family physician agreement with and adoption of universal hepatitis B immunization. J Fam Pract 1996; 42: 587–92.PubMedGoogle Scholar
  24. 24.
    Zimmerman RK, Santibanez TA, Fine MJ et al. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine 2003; 21: 1510–7.PubMedCrossRefGoogle Scholar
  25. 25.
    Bovier PA, Chamot E, Bouvier Gallacchi M, Loutan L. Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine 2001; 19: 4760–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Mieczkowski TA, Wilson SA. Adult pneumococcal vaccination: a review of physician and patient barriers. Vaccine 2002; 20: 1383–92.PubMedCrossRefGoogle Scholar
  27. 27.
    Motbey C. Pneumococcal polysaccharide vaccination in Australia: an examination of barriers and arguments in support of the hospital based approach. Hum Vaccin 2008; 4: 341–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Schmitt HJ, Booy R, Aston R et al. How to optimise the coverage rate of infant and adult immunisations in Europe. BMC Med 2007; 5: 11.PubMedCrossRefGoogle Scholar
  29. 29.
    Kroneman M, Paget WJ, van Essen GA. Influenza vaccination in Europe: an inventory of strategies to reach target populations and optimise vaccination uptake. Euro Surveill 2003; 8: 130–8.PubMedGoogle Scholar
  30. 30.
    Hofmann F, Ferracin C, Marsh G, Dumas R. Influenza vaccination of healthcare workers: a literature review of attitudes and beliefs. Infection 2006; 34: 142–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Brabin L, Greenberg DP, Hessel L, Hyer R, Ivanoff B, Van Damme P. Current issues in adolescent immunization. Vaccine 2008; 26: 4120–34.PubMedCrossRefGoogle Scholar
  32. 32.
    Kahn JA, Zimet GD, Bernstein DI et al. Pediatricians’ intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005; 37: 502–10.PubMedCrossRefGoogle Scholar
  33. 33.
    McInerny TK, Cull WL, Yudkowsky BK. Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations. Pediatrics 2005; 115: 833–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Loewenson PR, White KE, Osterholm MT, MacDonald KL. Physician attitudes and practices regarding universal infant vaccination against hepatitis B infection in Minnesota: implications for public health policy. Pediatr Infect Dis J 1994; 13: 373–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Johnson DR, Nichol KL, Lipczynski K. Barriers to adult immunization. Am J Med 2008; 121: S28–35.PubMedCrossRefGoogle Scholar
  36. 36.
    Zebrack JR, Brown KW. Preventive health for women: screening and immunizations. Med Clin North Am 2008; 92: 1011–35, ix.PubMedCrossRefGoogle Scholar
  37. 37.
    Bloom H. Immunizations: Not just for kids. In: International Longevity Center — USA. http://www.ilcusa.org/pages/publications/ageism-sleep/immunizations-not-just-for-kids.php. New York: International Longevity Center — USA; 2007: 1–8.
  38. 38.
    Fedson DS. Influenza prevention and control. Past practices and future prospects. Am J Med 1987; 82: 42–7.Google Scholar
  39. 39.
    Fedson DS, Houck P, Bratzler D. Hospital-based influenza and pneumococcal vaccination: Sutton’s Law applied to prevention. Infect Control Hosp Epidemiol 2000; 21: 692–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Sokos DR, Skledar SJ, Ervin KA et al. Designing and implementing a hospital-based vaccine standing orders program. Am J Health Syst Pharm 2007; 64: 1096–102.PubMedCrossRefGoogle Scholar
  41. 41.
    Gazmararian JA, Williams MV, Peel J, Baker DW. Health literacy and knowledge of chronic disease. Patient Educ Couns 2003;51:267–75.PubMedCrossRefGoogle Scholar
  42. 42.
    Jacobson TA, Thomas DM, Morton FJ, Offutt G, Shevlin J, Ray S. Use of a low-literacy patient education tool to enhance pneumococcal vaccination rates. A randomized controlled trial. JAMA 1999; 282: 646–50.Google Scholar
  43. 43.
    Berg GD, Thomas E, Silverstein S, Neel CL, Mireles M. Reducing medical service utilization by encouraging vaccines: randomized controlled trial. Am J Prev Med 2004; 27: 284–8.PubMedGoogle Scholar
  44. 44.
    Martinache V. Vaccin contre la grippe: démarche simplifiée pour 5 millions d’assurés. Agency-France Press Release, 2008 September, 23.Google Scholar
  45. 45.
    Buttler R. Maintaining healthy lifestyles: International Longevity Center — USA — Canyon Ranch report; 2000.Google Scholar

Copyright information

© Springer Internal Publishing Switzerland 2009

Authors and Affiliations

  1. 1.Department of Health Policy and ManagementState University of New York, Downstate Medical CenterBrooklynUSA
  2. 2.Department of Rehabilitation and GeriatricsGeneva Medical School and University HospitalsThonex-GeneveSwitzerland

Personalised recommendations